Aragon clinches $25m in series B
This article was originally published in Clinica
Executive Summary
Palo Alto, California-based surgical device developer Aragon Surgical has closed a $25m series B financing round led by Cay City Capital. Integral Capital Partners, as well as existing investors Delphi Ventures and ONSET Ventures, also participated in the fundraising. Aragon launched its first product, the LapCap pneumoperitoneum creation assist device, in September 2007 and said it has "several additional products in development".